Optimizing Emergency Medicine Pharmacists’ Practice During the COVID-19 Pandemic

Wieruszewski, Erin D; Mattson, Alicia E.; Manuel, Francis C; Brown, Caitlin S.

doi:10.1177/08971900211004838

Cited by 2 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite these challenges, numerous opportunities have elicited the critical role of clinical pharmacists in pandemics and public healthcare emergencies (Table 2). Some major examples in the inpatient setting included the utilization of advanced technology to provide remote counseling to healthcare providers (telehealth services), remote therapeutic drug monitoring (TDM) (telemonitoing) of hospitalized patients, and virtual rounding (Aburas et al, 2020;Allison et al, 2021;Arain et al, 2021;Aruru et al, 2021;Bhat and Kehasse, 2020;Danelich et al, 2021;Herzik et al, 2021;Li et al, 2021;Marchese et al, 2021;Meng et al, 2020;Muflih et al, 2021;Song et al, 2021;Surapat et al, 2021;Thomas et al, 2021;Wieruszewski et al, 2021;Zheng et al, 2021;Zhou et al, 2021). One hospital described a technology named Connect Care Pro, which was utilized during the pandemic (Kjerengtroen et al, 2020).…”

Section: General Clinical Pharmacistsmentioning

confidence: 99%

“…In another institution (Mayo Clinic, Rochester, MN), emergency medicine pharmacists developed strategies to preserve personal protective equipment and limit exposure to COVID-19 in patients placed in isolation. They anticipated the needs of patients as much as possible, delivering medications in the most finalized dosage forms, priming the IV lines, and programming the pump infusion prior to medication delivery to the room (Wieruszewski et al, 2021). Uninterrupted code blue response was provided by two clinical pharmacists in one institution, where the responding pharmacists participated by preparing the medications and providing counseling to the providers who were inside the patient room via mobile phone (Danelich et al, 2021).…”

Section: Specialized Clinical Pharmacistsmentioning

confidence: 99%

See 1 more Smart Citation

Challenges and opportunities of clinical pharmacists during COVID-19: A review of the literature

Thabit¹,

José²

2022

j app pharm sci

View full text Add to dashboard Cite

The success and sustainability of any profession can be evident during times of crises. Clinical pharmacists adapted and adopted multiple roles, which were an extension of their routine activities including a few new activities depending on the situation demands. Numerous studies in the literature discussed the various roles played and the activities offered by clinical pharmacists during the coronavirus disease of 2019 (COVID-19) pandemic. The challenges and opportunities faced by the clinical pharmacists during this time are worth contemplating. We aimed to summarize the challenges faced by clinical pharmacists during the pandemic and the opportunities that arose. Providing direct patient care, change in scheduling, and burnout were among the top challenges. Telehealth services and participation in guideline development and education were among the prominent opportunities. A discouraging finding was the lack of adequate recognition along with other front-line workers. The pandemic was a clear indicator of the significant role a clinical pharmacist plays in the healthcare team. Measures need to be taken by clinical pharmacists to ensure authorities are well-informed of their activities. It is also recommended to incorporate these experiences in pharmacy degree programs to ensure that pharmacists are better prepared for any future health or natural crises.

show abstract

Section: General Clinical Pharmacistsmentioning

confidence: 99%

Section: Specialized Clinical Pharmacistsmentioning

confidence: 99%

Challenges and opportunities of clinical pharmacists during COVID-19: A review of the literature

Thabit¹,

José²

2022

j app pharm sci

View full text Add to dashboard Cite

show abstract

“…Telemedicine has particularly been found to have an integral role in optimizing patient care during the coronavirus disease 2019 (COVID-19) pandemic and will continue to evolve as we adapt healthcare practices and prepare for future pandemics. 6 , 7 This report describes the services provided as part of the ED telemedicine and telepharmacy service.…”

mentioning

confidence: 99%

Description of telepharmacy services by emergency medicine pharmacists

Manuel

Wieruszewski

Brown

et al. 2022

American Journal of Health-System Pharmacy

View full text Add to dashboard Cite

Disclaimer In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose Utilization of telemedicine and telepharmacy services has become increasingly popular, as specifically noted during the coronavirus disease 2019 (COVID-19) pandemic. This article describes the implementation of and services provided by emergency medicine pharmacists (EMPs) as part of a telemedicine team in the emergency department (ED). Summary This report describes the telemedicine and telepharmacy services provided to EDs in the Mayo Clinic Health System from the Mayo Clinic Rochester ED. Telepharmacy services provided by EMPs started in 2018. EMPs cover telepharmacy calls as part of their shift within the ED in Rochester. Recommendations and interventions are documented in the electronic medical record. A retrospective review evaluated interventions provided from November 18, 2018, through November 10, 2020. Baseline patient demographics, as well as the type and number of interventions provided by EMPs, hospital site, and time spent on the interventions, were collected. Telepharmacy consults could include multiple interventions and be classified as more than one type of intervention. During this time period, 24 pharmacists worked in the ED and were able to provide telepharmacy services. There were 279 consults included in this study, with 435 interventions. Most of the calls came from critical access hospitals (48.7%). The most common types of interventions documented were medication selection and dosing (n = 238), antimicrobials (n = 141), monitoring and follow-up (n = 65), discharge (n = 56), drug information (n = 55), and allergy review (n = 50). Conclusion Telepharmacy services can provide increased access to emergency medicine specialty pharmacists in areas that would not otherwise have these services.

show abstract

Optimizing Emergency Medicine Pharmacists’ Practice During the COVID-19 Pandemic

Cited by 2 publications

References 13 publications

Challenges and opportunities of clinical pharmacists during COVID-19: A review of the literature

Challenges and opportunities of clinical pharmacists during COVID-19: A review of the literature

Description of telepharmacy services by emergency medicine pharmacists

Contact Info

Product

Resources

About